BioCryst Pharmaceuticals (BCRX) is a Great Momentum Stock: Should You Buy?Zacks Investment Research • 06/04/25
BioCryst to Present New Data at 2025 Meeting of the European Academy of Allergy and Clinical ImmunologyGlobeNewsWire • 06/02/25
BioCryst Highlights Real-world Data Showing ORLADEYO® (berotralstat) Consistently Reduces HAE Attacks Across All AgesGlobeNewsWire • 05/30/25
Wall Street Analysts Believe BioCryst (BCRX) Could Rally 55.81%: Here's is How to TradeZacks Investment Research • 05/26/25
BioCryst Presents New Real-world Evidence Showing Significant and Sustained Reductions in HAE Attack Rates in Adolescents and People with Severe HAE Following Initiation of ORLADEYO® (berotralstat)GlobeNewsWire • 05/16/25
BioCryst Announces FDA Acceptance of NDA for ORLADEYO® (berotralstat) Oral Granules in Patients with Hereditary Angioedema Aged 2 to 11 YearsGlobeNewsWire • 05/14/25
What Makes BioCryst Pharmaceuticals (BCRX) a Strong Momentum Stock: Buy Now?Zacks Investment Research • 05/08/25
Does BioCryst (BCRX) Have the Potential to Rally 61.21% as Wall Street Analysts Expect?Zacks Investment Research • 05/08/25
BioCryst Pharmaceuticals Soars 23% In One Session - Here's Why It Surprised InvestorsBenzinga • 05/05/25
BioCryst Pharmaceuticals (BCRX) Reports Break-Even Earnings for Q1Zacks Investment Research • 05/05/25
BioCryst Reports First Quarter 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 05/05/25
BioCryst Pharmaceuticals (BCRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 04/28/25
How BioCryst Pharmaceuticals, Inc. (BCRX) Stock Stands Out in a Strong IndustryZacks Investment Research • 04/10/25
BioCryst (BCRX) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 02/27/25
Here's Why BioCryst (BCRX) Could be Great Choice for a Bottom FisherZacks Investment Research • 02/26/25
Wall Street Analysts Predict an 84.18% Upside in BioCryst (BCRX): Here's What You Should KnowZacks Investment Research • 02/26/25